Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis
July 16, 2025
July 16, 2025
BOSTON, Massachusetts, July 16 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release on July 15, 2025:
* * *
Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis
Independent appraisal committee voted that current evidence is not adequate to demonstrate a net health benefit of tolebrutinib compared to best supportive care
*
* * *
Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis
Independent appraisal committee voted that current evidence is not adequate to demonstrate a net health benefit of tolebrutinib compared to best supportive care
*